NCT02952066 (TRPV1) is a NA clinical trial of Bronchial biopsy in Moderate Persistent Asthma, sponsored by Lu Yuan Lee.

Who is sponsoring NCT02952066?

NCT02952066 is sponsored by Lu Yuan Lee.

What drugs are being tested in NCT02952066?

Interventions in NCT02952066: Bronchial biopsy.

What condition does NCT02952066 study?

NCT02952066 studies Moderate Persistent Asthma, Severe Persistent Asthma, Nodule Solitary Pulmonary, Pulmonary Atelectasis.

Is NCT02952066 still recruiting?

NCT02952066 is currently withdrawn. Last updated 14 June 2021.

Last reviewed 2021-06-14 · How we verify

NCT02952066: TRPV1

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Expressions of TRPV1 in Airway of Asthmatics

Withdrawn NA Last updated 14 June 2021

What this trial tests

NA trial testing Bronchial biopsy in Moderate Persistent Asthma. Withdrawn.

Timeline

20 September 2017

Primary endpoint
20 November 2018

20 November 2018

Quick facts

Lead sponsor	Lu Yuan Lee
Phase	NA
Status	Withdrawn
Study type	INTERVENTIONAL
Allocation	na
Design	single group
Masking	none
Primary purpose	basic science
Start date	20 September 2017
Primary completion	20 November 2018
Estimated completion	20 November 2018
Sites	1 location across United States

Drugs / interventions tested

Bronchial biopsy

Conditions studied

Moderate Persistent Asthma — all drugs for Moderate Persistent Asthma →
Severe Persistent Asthma — all drugs for Severe Persistent Asthma →
Nodule Solitary Pulmonary — all drugs for Nodule Solitary Pulmonary →
Pulmonary Atelectasis — all drugs for Pulmonary Atelectasis →

Sponsor

Lu Yuan Lee — full company profile →

Who can join

Adults 18 to 60, any sex, with Moderate Persistent Asthma or Severe Persistent Asthma. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The purpose of this study is to measure the density of a temperature-sensitive protein, named TRPV1, in the airway mucosa tissue of both non-asthmatic and moderate to severe persistent asthmatic patients. This study may generate information for developing new therapeutic strategy.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other trials of Bronchial biopsy

Trials testing the same drug.

NCT03181204 — Modeling Bronchial Epithelium Modifications Associated With COPD Using iPS · completed

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT02952066 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Lu Yuan Lee
Last refreshed: 14 June 2021

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT02952066.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing